Adrian Schreiber

10PUBLICATIONS
21CO-AUTHORS
Haematological tumoursAquaculture and fisheries stock assessmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instrumental methods (excl. immunological and bioassay methods)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2026
Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission.

|Jul 13, 2026
Trial End Points in Anti-neutrophil Cytoplasmic Antibody‑Associated Vasculitis: Are We Missing the Boat?

|Dec 15, 2025
CAR-T cells targeting CD19 for the treatment of ANCA vasculitis.

Dörte Lodka, Adrian Schreiber

|Mar 12, 2025
Highlights from the plenary session: cellular and molecular mechanisms of disease (I).

Jonas Zimmermann, Adrian Schreiber, Peter Heeringa

|Jun 06, 2024
Authors' Reply: Utility of Urinary CD4 + T-Cell Count in Detecting ANCA-Associated Vasculitis Renal Relapse.

Luka Prskalo, Adrian Schreiber, Philipp Enghard

|Jan 05, 2024
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury.

Dörte Lodka, Maria Zschummel, Mario Bunse

Pageof 2

Frequent Collaborators

2 joint publications

Philipp Enghard

2 joint publications

Ralph Kettritz

1 joint publications

Udo Schneider

1 joint publications

Lennard Ostendorf